Literature DB >> 15278267

Coagulation disorders of cardiopulmonary bypass: a review.

Domenico Paparella1, Stephanie J Brister, Michael R Buchanan.   

Abstract

BACKGROUND: Postoperative bleeding is one of the most common complications of cardiac surgery. DISCUSSION: Extensive surgical trauma, prolonged blood contact with the artificial surface of the cardiopulmonary bypass (CPB) circuit, high doses of heparin, and hypothermia are all possible triggers of a coagulopathy leading to excessive bleeding. Platelet activation and dysfunction also occur and are caused mainly by heparin, hypothermia, and inadequate protamine administration. Heparin and protamine administration based on heparin concentrations as opposed to fixed doses may reduce coagulopathy and postoperative blood loss.
CONCLUSIONS: A better comprehension of the multifactorial mechanisms of activation of coagulation, inflammation, and fibrinolytic pathways during CPB may enable a more effective use of the technical and pharmaceutical options which are currently available.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278267     DOI: 10.1007/s00134-004-2388-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  87 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

2.  Platelet function in cardiac surgery: influence of temperature and aprotinin.

Authors:  J Boldt; C Knothe; B Zickmann; S Bill; F Dapper; G Hempelmann
Journal:  Ann Thorac Surg       Date:  1993-03       Impact factor: 4.330

3.  Reoperations for bleeding after coronary artery bypass procedures during 25 years.

Authors:  M Sellman; M A Intonti; T Ivert
Journal:  Eur J Cardiothorac Surg       Date:  1997-03       Impact factor: 4.191

4.  Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.

Authors:  L Knudsen; J M Hasenkam; H H Kure; P Hughes; L Bellaiche; P Ahlburg; C Djurhuus
Journal:  Thromb Res       Date:  1996-10-01       Impact factor: 3.944

5.  Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.

Authors:  Gabriel S Aldea; Louise O Soltow; Wayne L Chandler; Christopher M Triggs; Craig R Vocelka; Gregory I Crockett; Yong T Shin; William E Curtis; Edward D Verrier
Journal:  J Thorac Cardiovasc Surg       Date:  2002-04       Impact factor: 5.209

6.  Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.

Authors:  T Kojima; S Gando; O Kemmotsu; H Mashio; Y Goda; H Kawahigashi; N Watanabe
Journal:  J Cardiothorac Vasc Anesth       Date:  2001-02       Impact factor: 2.628

7.  Reduction of heparin dose is not beneficial to platelet function.

Authors:  T Nakajima; K Kawazoe; K Ishibashi; Y Kubota; T Sasaki; H Izumoto; T Nitatori
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

8.  Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.

Authors:  H te Velthuis; C Baufreton; P G Jansen; C M Thijs; C E Hack; A Sturk; C R Wildevuur; D Y Loisance
Journal:  J Thorac Cardiovasc Surg       Date:  1997-07       Impact factor: 5.209

9.  Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.

Authors:  H Huang; W Ding; Z Su; W Zhang
Journal:  J Thorac Cardiovasc Surg       Date:  1993-07       Impact factor: 5.209

10.  Heparin neutralization by recombinant platelet factor 4 and protamine.

Authors:  J H Levy; J G Cormack; A Morales
Journal:  Anesth Analg       Date:  1995-07       Impact factor: 5.108

View more
  64 in total

Review 1.  [Type A dissection. Principles of anesthesiological management].

Authors:  J Roggenbach; H Rauch
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

2.  Hemoglobin optimization and transfusion strategies in patients undergoing cardiac surgery.

Authors:  Mahdi Najafi; David Faraoni
Journal:  World J Cardiol       Date:  2015-07-26

3.  Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.

Authors:  Alice Wiefferink; Patrick W Weerwind; Waander van Heerde; Steven Teerenstra; Luc Noyez; Ben E de Pauw; René M H J Brouwer
Journal:  J Extra Corpor Technol       Date:  2007-06

Review 4.  [Management of hemostasis disorders after extracorporeal circulation. A clinical therapy algorithm].

Authors:  C Jámbor; D Bremerich; A Moritz; E Seifried; B Zwissler
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

5.  Changes in activated partial thromboplastin time and international normalised ratio after on-pump and off-pump surgical revascularization of the heart.

Authors:  Lejla Selimović Čeke; Semir Imamović; Farid Ljuca; Zoran Jerkić; Goran Imamović; Munevera Hadžimešić; Aida Pojskić; Jasmina Kovčić
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

6.  TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage.

Authors:  Kevin Fleming; Roberta E Redfern; Rebekah L March; Nathan Bobulski; Michael Kuehne; John T Chen; Michael Moront
Journal:  J Extra Corpor Technol       Date:  2017-12

7.  Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study.

Authors:  P Gueret; S Combe; C Krezel; E Fuseau; P L M van Giersbergen; M Petitou; E Neuhart
Journal:  Eur J Clin Pharmacol       Date:  2016-10-15       Impact factor: 2.953

8.  Thromboelastographic changes after gonadectomy in retired racing greyhounds.

Authors:  P Vilar Saavedra; N Stingle; C Iazbik; L Marín; M A McLoughlin; Y Xie; G Couto
Journal:  Vet Rec       Date:  2011-07-01       Impact factor: 2.695

9.  Biocompatibility assessment of a long-term wearable artificial pump-lung in sheep.

Authors:  Kang Zhou; Shuqiong Niu; Giacomo Bianchi; Xufeng Wei; Narayana Garimella; Bartley P Griffith; Zhongjun J Wu
Journal:  Artif Organs       Date:  2013-03-03       Impact factor: 3.094

10.  Antithrombin Administration During Intravenous Heparin Anticoagulation in the Intensive Care Unit: A Single-Center Matched Retrospective Cohort Study.

Authors:  Jacob T Beyer; Kelly E Schoeppler; Giorgio Zanotti; Gregory M Weiss; Scott W Mueller; Robert MacLaren; Douglas N Fish; Tyree H Kiser
Journal:  Clin Appl Thromb Hemost       Date:  2016-09-13       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.